Company and Stock Identity

How Philips Connects to the Public Market

Company structure
Public company
Market access
Direct listings: NYSE: PHG and Euronext Amsterdam: PHIA.
Stock name
Koninklijke Philips N.V.
Ticker and exchange
NYSE / Euronext Amsterdam: PHG / PHIA
Research focus
Separate AI-enabled healthcare products from the full Philips business and distinguish commissioned market research from independent clinical evidence for a specific product.

Royal Philips is publicly listed in Amsterdam, with American depositary shares traded in New York.

Dated Market Snapshot

Oct 26, 2026

Last price
$26.57
Change
-1.19%
Previous close
$26.89
52-week high / low
$33.435/$23.62
Market cap
26,115,248,791

Automated from Nasdaq. Check the exchange or investor-relations page for the current price.

Open the public company market data feed for the full directory, ownership relationships, stock identifiers, and dated snapshots.

First-Hand Company News

Latest Developments

... Philips ... Company source

Philips says its SmartSpeed Precise MRI software has reached 1,000 installations

Philips said on 14 October 2026 that it had reached 1,000 global installations of SmartSpeed Precise, its AI-based MRI image reconstruction software. The company says the software is used in at least 95 percent of compatible clinical scanning on the systems where it is installed. Its stated performance claims are that SmartSpeed Precise delivers images up to 80 percent sharper and lets scans be completed up to three times faster compared with Philips SENSE imaging, that it can save an average of 215 hours of scanning time per system per year, and that this represents capacity for roughly 624 additional MRI examinations per system each year, or about 215,000 hours and more than 624,000 additional examinations across all 1,000 systems. Ioannis Panagiotelis, business leader for MRI at Philips, is quoted saying faster is only meaningful when it comes with the image quality clinicians need.

Why it matters: The adoption figure is the useful part of this announcement. Plenty of imaging AI gets bought, installed and then left switched off because it slows the technologist down or the radiologists do not trust the output, so a vendor claiming the software runs on nearly every eligible scan is making a claim it can be checked on. The time figures need more care. The 215 hours and the 624 extra examinations are Philips arithmetic built on its own comparison against its older SENSE method, not an independent measurement, and extra scanner capacity only turns into extra examinations if a department also has the staff and the referrals to fill it. Nothing here is a clinical claim, and faster scans with sharper pictures do not by themselves mean a better diagnosis.

... Philips ... Company research

Philips publishes its 2026 United States healthcare AI survey

Philips reported survey findings on clinician AI use, time savings, capacity, safety, training, and readiness in the United States.

Why it matters: The report gives a current picture of clinician attitudes and claimed time savings. It also comes from a company with a commercial interest in healthcare technology adoption. That does not make the findings useless. It means the survey method and independent comparisons carry more weight.

See company developments across the healthcare AI market.

Careers and Qualifications

What to Know Before Applying

Work areas: Clinical applications, imaging, ultrasound, monitoring, informatics, software, data science, regulatory affairs, service, and product work.

Qualification signal: Clinical application and field roles often need modality or professional experience, while software roles need regulated-product delivery. Check the exact country and business unit before choosing training.

Check current roles at Philips. A careers page is the source of record for openings. This profile does not claim a role is open unless the company lists it now.

Related Healthcare AI Roles

Training to Compare

Buyer Snapshot

Best-fit buyer
Radiology leadership, pathology leadership, clinical informatics, imaging IT, patient safety, and procurement
Primary use case
Triage studies, flag findings, support image interpretation, and coordinate time-sensitive care
Typical deployment
Usually integrated with PACS, RIS, worklists, or digital pathology systems and monitored inside the clinical workflow

Evidence questions

  • Was the tool tested prospectively and independently on comparable equipment and patients?
  • What are sensitivity, specificity, false positive workload, and time-to-action effects?
  • How does performance vary by site, scanner, demographic subgroup, and disease prevalence?

Regulatory and workflow questions

  • Which FDA authorization covers the exact product version, modality, and intended use?
  • Who retains final clinical responsibility and how is disagreement with the AI handled?
  • What post-deployment monitoring and material update notification does the vendor provide?

Data and contract questions

  • Where are images and derived data processed and retained?
  • Which PACS, RIS, pathology, and EHR integrations are supported in production?
  • Can data be used for model improvement, and what controls govern secondary use?

Evidence and Regulation

FDA Clearances on Record

No clearance is linked in this directory. That is not automatically a mark against the company. Some products support the people doing the work instead of reading a patient image or signal themselves.

What the Published Research Says About This Work

Independent studies on the work itself help separate category evidence from one company's claims.

First-Hand Sources